Showing 3511-3520 of 5062 results for "".
DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologiDermWireTV: Galderma Gets Cheeky, COVID Vax & Skin, AKN Classification
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-galderma-gets-cheeky-covid-vax-skin-akn-classification/19955/Only a small percentage of patients have skin reactions to COVID-19 vaccines, but true allergic reactions must be identified. FDA approves Restylane Contour from Galderma. New classification may aid treatment selection or acne keloidalis.Antibiotics and Cosmetic Trends; Seysara Launches
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-antibiotics-and-cosmetics-trends-seysara-launches/19532/Dermatologists are prescribing fewer antibiotics to manage acne and rosacea. But, the use of antibiotics after surgical procedures is on the rise. More than one third of American adults are considering a cosmetic treatment in 2019, results of a RealSelf survey show. Seysara (sarecycline), a novel teValeant's Plan for Derm; VCS Highlights
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-valeant-s-plan-for-derm-vcs-highlights/18587/Amid reports that its Obagi and Solta units may be sold off, Valeant Pharmaceuticals is assuring investors that the company is focused on the future and has plans to fix its dermatology unit. Vegas Cosmetic Surgery has wrapped up its 12th program, gathering dermatologists, plastic surgeons, facial pBuilding a Compelling Brand for Your Healthcare Practice
https://practicaldermatology.com/topics/practice-management/building-a-compelling-brand-for-your-healthcare-practice--ovugeroo/18887/It's all about the brand. Know how to successfully develop and convey your brand to visitors online—current and potential patients both. An Ekwa Educational Video.DermwireTV — Bayer Buys Merck’s OTC Lines, Allergan Rejects Valeant Bid
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-mdash-bayer-buys-merck-rsquo-s-otc-lines-allergan-rejects-valeant-bid/19134/Bayer Purchases Merck's OTC Products and Allergan Rebuffs Valeant. This week DermWireTV explores Bayer's growth in the OTC space, including sunscreens, and reports new data on skin cancer mortality. Also in this edition: Neal Bhatia, MD reviews the Noah Worcester Society Annual Meeting.Why Lutronic
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/why-lutronic/19188/Established in 1997 by a group of accomplished scientists and prominent members of the medical community, LUTRONIC is passionate about improving the lives of physicians and their patients by developing solutions that are intuitive, versatile, and efficacious. Our customers choose our systems becauseMYDON by Quantel Derma - Perfect for Spider Veins
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/mydon-by-quantel-derma-perfect-for-spider-veins/19375/The Nd:YAG laser system is the ideal treatment solution for vascular skin changes such as spider veins or varicosis. With proven 1064 nm wavelength and integrated contact cooling before, during and after each laser pulse. The effective Burst Mode lets you treat vessels of up to 5 mm. Various handpieHow to Choose the Right Filler
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-to-choose-the-right-filler/19411/Dr. Amy Derick reviews key points about injectable fillers, a non-invasive alternative to surgical facelifts.Chemical Peels for Periocular Lentigines
https://practicaldermatology.com/conferences/noah-worcester/chemical-peels-for-periocular-lentigines/57073/Kachiu Lee, MD, MPH, discusses her presentation, “Treatment of Periocular Lentigines with Chemical Peels: A Clinical Pearl,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.